Personnel

THYMITAQ maker adds three new members to management team

Published in Health and Medicine Week, May 23rd, 2005

Eximias Pharmaceutical Corp. announced that it has appointed a new CFO, vice president of operations, and vice president of business development to round out the company's expanded management team.

Jeff Randall has been named CFO, Gary Floyd has been named vice president of operations, and John Bennett has been named vice president of business development. The announcement came 1 week after the company disclosed the completion of enrollment in its pivotal phase III clinical study with THYMITAQ (nolatrexed), an investigational product, for the treatment of inoperable primary liver cancer (hepatocellular carcinoma).

Jeff Randall brings over 20 years of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2005-05-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry